Diarylheptanoids suppress proliferation of pancreatic cancer PANC-1 cells through modulating shh-Gli-FoxM1 pathway
Pancreatic cancer is one of the leading causes of cancer, and it has the lowest 5-year survival rates. It is necessary to develop more potent anti-pancreatic cancer drugs to overcome the fast metastasis and resistance to surgery, radiotherapy, chemotherapy, and combinations of these. We have identif...
Saved in:
Published in | Archives of pharmacal research Vol. 40; no. 4; pp. 509 - 517 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Seoul
Pharmaceutical Society of Korea
01.04.2017
대한약학회 |
Subjects | |
Online Access | Get full text |
ISSN | 0253-6269 1976-3786 |
DOI | 10.1007/s12272-017-0905-2 |
Cover
Summary: | Pancreatic cancer is one of the leading causes of cancer, and it has the lowest 5-year survival rates. It is necessary to develop more potent anti-pancreatic cancer drugs to overcome the fast metastasis and resistance to surgery, radiotherapy, chemotherapy, and combinations of these. We have identified several diarylheptanoids as anti-pancreatic cancer agents from
Alpinia officinarum
(lesser galangal) and
Alnus japonica
. These diarylheptanoids suppressed cell proliferation and induced the cell cycle arrest of pancreatic cancer cells (PANC-1). Among them, the most potent compounds
1
and
7
inhibited the shh-Gli-FoxM1 pathway and their target gene expression in PANC-1 cells. Furthermore, they suppressed the expression of the cell cycle associated genes that were rescued by the overexpression of exogenous FoxM1. Taken together, (E)-7-(4-hydroxy-3-methoxyphenyl)-1-phenylhept-4-en-3-one (
1
) from
Alpinia officinarum
(lesser galangal) and platyphyllenone (
7
) from
Alnus japonica
inhibit PANC-1 cell proliferation by suppressing the shh-Gli-FoxM1 pathway, and they can be potential candidates for anti-pancreatic cancer drug development. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000010.2017.40.4.010 |
ISSN: | 0253-6269 1976-3786 |
DOI: | 10.1007/s12272-017-0905-2 |